Current Filters

Showing 71 - 80 results of 3489

Rivaroxaban (Xarelto) (Last Updated: Oct 27, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Xarelto
Manufacturer:
Bayer Inc.
Submission Type:
Request For Advice
Indications:

Deep-Vein Thrombosis (treatment), without Symptomatic Pulmonary Embolism

Palonosetron hydrochloride (Aloxi (capsule)) (Last Updated: Oct 5, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Aloxi (capsule)
Manufacturer:
Eisai Ltd.
Submission Type:
Initial
Indications:

Nausea and vomiting (chemotherapy induced) prevention

Palonosetron hydrochloride (Aloxi (injection)) (Last Updated: Oct 5, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Aloxi (injection)
Manufacturer:
Eisai Ltd.
Submission Type:
Initial
Indications:

Nausea and vomiting (chemotherapy induced) prevention

Pirfenidone (Esbriet) (Last Updated: Oct 5, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Esbriet
Manufacturer:
InterMune Canada Inc.
Submission Type:
Initial
Indications:

Pulmonary fibrosis (idiopathic, mild to moderate)

Ivacaftor (Kalydeco) (Last Updated: Sep 21, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Kalydeco
Manufacturer:
Vertex Pharmaceuticals Inc.
Submission Type:
Initial
Indications:

Cystic Fibrosis patients (G551D mutation)

Apixaban (Eliquis) (Last Updated: Sep 25, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Eliquis
Manufacturer:
Bristol-Myers Squibb Canada and Pfizer Canada Inc. Alliance
Submission Type:
Initial
Indications:

Thromboembolic events prevention, (atrial fibrillation)

Grass Pollen Allergen Extract (Oralair) (Last Updated: Sep 7, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Oralair
Manufacturer:
Paladin Labs Inc.
Submission Type:
Initial
Indications:

Allergic rhinitis (grass pollen)

Collagenase clostridium histolyticum (Xiaflex) (Last Updated: Aug 30, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Xiaflex
Manufacturer:
Auxilium Pharmaceuticals, Inc. & Actelion Pharmaceuticals Canada Inc.
Submission Type:
Initial
Indications:

Dupuytren’s contracture with a palpable cord

Tolvaptan (Samsca) (Last Updated: Jul 3, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Samsca
Manufacturer:
Otsuka Canada Pharmaceutical Inc.
Submission Type:
Initial
Indications:

Hyponatremia, non-hypovolemic

Download results as CSV